Moreover, HER2-overexpressing breast cancer cell lines express a full-length HER2 molecule on exosomes, which can bind to the HER2 antibody Trastuzumab to nullify its effect on tumor proliferation104. This evidence concerns the gene ERBB2 and breast carcinoma.